Phase I-II trial of mitoxantrone in acute leukemia.

Arlin, Z A; Silver, R; Cassileth, P; Armentrout, S; Gams, R; Daghestani, A; Coleman, M; Schoch, I; Dukart, G

Arlin, Z A; Silver, R; Cassileth, P; Armentrout, S; Gams, R; Daghestani, A; Coleman, M; Schoch, I; Dukart, G.

Cancer Treat Rep ; 69(1): 61-4, 1985 Jan.

Article in En | MEDLINE | ID: mdl-3855386

Subject(s)

Anthraquinones/therapeutic use; Leukemia/drug therapy; Acute Disease; Adult; Aged; Anthraquinones/adverse effects; Drug Evaluation; Female; Heart/drug effects; Humans; Leukemia, Lymphoid/drug therapy; Leukemia, Myeloid/drug therapy; Liver/drug effects; Male; Middle Aged; Mitoxantrone; Nausea/chemically induced; Recurrence; Stomatitis/chemically induced; Vomiting/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Anthraquinones Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Treat Rep Year: 1985 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links